Dana-Faber Cancer Institute Partners With Leukemia & Lymphoma Society for Clinical Trials

The Leukemia & Lymphoma Society has announced a partnership with the Dana-Faber Cancer Institute in Boston to create a network of sites for clinical trials for blood cancer therapies.

Advertisement

The Blood Cancer Research Partnership will work with community oncology settings to expand access to these trials to more patients.

More Articles on Research Partnerships:

Greenville Health System, Clemson University Form Research Partnership
Columbia University, Chinese Center for Disease Control Partner for Beijing Pathogen Discovery Lab
Vanderbilt, West Tennessee Healthcare Partner for Cancer Program

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Uncategorized

Advertisement

Comments are closed.